Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-38.82%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-38.82%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-8x
Never
—
—
Never
—
5 Years
Score—
Net Growth-8x
Net TrendNever
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Vaxcyte Inc fundamental performance
Across Vaxcyte Inc's full reported history, from 2020 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 89M to -$ 766M. Revenue increased in 0% of the years measured; net income in 0%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 59.65 | — |
1 Year2025-08-12 | $ 30.00 | 98.83% |
5 Years2021-08-12 | $ 26.66 | 123.74% |
All Time2020-06-12 | $ 26.15 | 128.11% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-06-12 |
|---|---|---|---|---|
| Price | $ 59.65 | $ 30.00 | $ 26.66 | $ 26.15 |
| Return | — | 98.83% | 123.74% | 128.11% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 1.06B | $ 1.48B |
| 2025 | $ 0.00 | -$ 766M | $ 1.56B |
| 2024 | $ 0.00 | -$ 463M | $ 1.74B |
| 2023 | $ 0.00 | -$ 402M | $ 1.08B |
| 2022 | $ 0.00 | -$ 223M | $ 931M |
| 2021 | $ 0.00 | -$ 100M | $ 245M |
| IPO2020 | $ 0.00 | -$ 89M | $ 386M |
Explore beyond PCVX
You're looking at Vaxcyte Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
